Kenneth W. Kinzler, Ph.D.

Professor of Oncology, Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

Dr. Ken W. Kinzler is a world recognized expert on the molecular and genetic analysis of human cancer.

Ken holds a Ph.D. from Johns Hopkins University School of Medicine.

He has been recognized for his role in uncovering the genetic alterations linked to the initiation of colon cancer; development of novel approaches for the molecular analysis of cancer; and more recently, for his role in deciphering the genetic blueprints of many types of cancer. In the late 2000s, Ken and Thrive co-founder Bert Vogelstein, M.D., led a team of scientists who decoded the genomes of many cancers, including breast, colon, pancreatic, brain, ovarian and liver. His work has spawned over 100 patent applications, most focused on the use of genetic approaches to improve the diagnosis and management of patients with cancers and other serious diseases.

Ken is currently professor of oncology at the Johns Hopkins University School of Medicine, co-director of the Ludwig Center at Johns Hopkins University and associate director for basic research for the Sidney Kimmel Comprehensive Cancer Center (SKCCC). He is also a member of the National Academy of Sciences, National Academy of Medicine, and National Academy of Inventors and is a fellow of American Association of Cancer Research Academy. Ken is the recipient of numerous awards for his genetic analyses of human cancer, including the inaugural National Brain Tumor Society Founders Award, the 2013 American Association for Cancer Research (AACR) Team Science Award for Pancreatic Cancer Research, the 2014 AACR Team Science Award for Brain Cancer Research and the 2017 AACR Team Science Award for Liquid Biopsies. He has co-authored more than 400 peer-reviewed articles on the molecular analyses of cancer.

Back to Who We Are